P. Spinhoven

2 papers in the library · publishing 2021-2022

Papers

Mindfulness-based cognitive group therapy for treatment-refractory anxiety disorder: A pragmatic randomized controlled trial.

Journal of Anxiety Disorders June 1, 2022 P. Spinhoven, E. Hoogerwerf, Anne E van Giezen et al.

Mindfulness-Based Cognitive Therapy (MBCT) led to larger reductions in anxiety, avoidance, emotion regulation difficulties, and worry, and larger increases in mindfulness skills, compared to Relapse Prevention-Cognitive Behavioral Therapy (CBT-RP) for outpatients with treatment-refractory anxiety disorders who had not responded sufficiently to first-line psychological treatment. At a 6-month follow-up, treatment gains were somewhat diminished. The effects of MBCT on anxiety at post-treatment were not mediated by mindfulness skills, emotion regulation, worry, or rumination at mid-treatment.

DOI: 10.1016/j.janxdis.2022.102599 Full text Medicine Psychology

Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness‐based cognitive therapy

Depression and Anxiety November 9, 2021 J. D. de Klerk-Sluis, M. Huijbers, S. Löcke et al.

Mindfulness-based cognitive therapy (MBCT) helps prevent relapse in major depressive disorder by reducing cognitive reactivity and rumination while increasing self-compassion and mindfulness. The authors note that while rumination and mindfulness after MBCT are linked to relapse, no prior research has examined whether these factors—along with cognitive reactivity and self-compassion—are associated with relapse before MBCT begins. This gap suggests that pre-treatment psychological characteristics may influence treatment outcomes, but the study does not report any new empirical data.

DOI: 10.1002/da.23220 Full text Medicine Psychology